Vista Pharmaceuticals Ltd — Important, 14-04-2026: Company Update

Vista Pharmaceuticals has confirmed its routine compliance regarding the dematerialization of shares. The company ensured that all securities received for conversion to electronic form were meticulously cancelled after verification, and the depository's name was accurately substituted as the registered owner in company records. This crucial process ensures investor shareholdings are properly managed and remain listed on the stock exchange, upholding transparency and maintaining accurate ownership records for all shareholders.